Feedback / Questions
ficerafusp alfa (BCA101) - Biocon
https://www.globenewswire.com/news-release/2026/01/12/3216819/0/en/Bicara-Therapeutics-Announces-Phase-3-Optimal-Dose-and-Provides-2026-Corporate-Outlook.html
Jan 12, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next